Pandey Rajendra Kumar, Arya Tung Vir Singh, Kumar Amit, Yadav Ashish
Department of Internal Medicine, Lala Lajpat Rai Medical College, Meerut, Uttar Pradesh, India.
Department of International Health, Global Disease Epidemiology and Control, John Hopkins Bloomberg School of Public Health, Baltimore, USA.
Int J Yoga. 2017 Jan-Apr;10(1):3-8. doi: 10.4103/0973-6131.186158.
To study the effect of 6 months yoga program in patients suffering from chronic kidney disease (CKD).
Fifty-four patients with CKD were studied and divided into two groups (yoga group and control group) to see the effect of yoga in CKD. Patients in the yoga group were offered yoga therapy along with other conventional treatment modalities, while the control group was only on conventional treatment. Subjects in yoga group were trained to perform specific yogic for at least 5 days a week for 40-60 min a day. Regular monitoring of blood pressure, renal function, requirement of a number of dialysis, and quality of life (QOL) indicators were done. Fifty patients (yoga - 25; control-25) completed 6 months follow-up.
In yoga group, a significant reduction of systolic and diastolic blood pressure, significant reduction in blood urea and serum creatinine levels, and significant improvement in physical and psychological domain of the World Health Organization QOL (as assessed by BREF QOL scores) were seen after 6 months. In control group, rise of blood pressure, deterioration of renal function, and QOL were observed. Poststudy comparison between the two groups showed a statistically significant reduction of blood pressure, nonsignificant reduction in blood urea and serum creatinine, and significant improvement in physical and psychological domain of QOL in yoga group as compared to control group. For subjects in yoga group, the need for dialysis was less when compared to control group although this difference was statistically insignificant. Except for inability of some patients to perform certain yogic no adverse effect was found in the study.
Six months yoga program is safe and effective as an adjuvant therapy in improving renal functions and QOL of CKD patients.
研究为期6个月的瑜伽项目对慢性肾脏病（CKD）患者的影响。
对54例CKD患者进行研究并分为两组（瑜伽组和对照组），以观察瑜伽对CKD的影响。瑜伽组患者在接受其他传统治疗方式的同时接受瑜伽治疗，而对照组仅接受传统治疗。瑜伽组的受试者接受训练，每周至少进行5天特定的瑜伽练习，每天40 - 60分钟。定期监测血压、肾功能、透析次数需求及生活质量（QOL）指标。50例患者（瑜伽组 - 25例；对照组 - 25例）完成了6个月的随访。
6个月后，瑜伽组收缩压和舒张压显著降低，血尿素和血清肌酐水平显著降低，世界卫生组织生活质量的生理和心理领域显著改善（通过BREF生活质量评分评估）。对照组观察到血压升高、肾功能恶化及生活质量下降。两组研究后比较显示，与对照组相比，瑜伽组血压显著降低，血尿素和血清肌酐降低不显著，生活质量的生理和心理领域显著改善。对于瑜伽组的受试者，与对照组相比透析需求较少，尽管这种差异无统计学意义。除了一些患者无法进行某些瑜伽练习外，研究中未发现不良反应。
为期6个月的瑜伽项目作为辅助治疗在改善CKD患者肾功能和生活质量方面是安全有效的。
